1h Free Analyst Time
The Continuous Renal Replacement Therapy Market size was estimated at USD 13.17 billion in 2022, USD 14.28 billion in 2023, and is expected to grow at a CAGR of 8.53% to reach USD 25.37 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Continuous renal replacement therapy (CRRT) is a specialized medical treatment utilized for continuous dialysis to allow solute and fluid homeostasis. CRRT provides continuous renal support by mimicking the natural function of the kidneys in removing waste products, excess fluids, and electrolytes from the blood while maintaining optimal acid-base balance. The CRRT is witnessing significant growth due to several factors, including the increasing prevalence of AKI incidences globally and rising technological advancements in extracorporeal dialysis and lithotripsy. In addition, significant advantages of CRRT in intermittent blood purification boost the market expansion. However, the high cost associated with the renal replacement procedure and concerns over potential complications during therapies subsequently hampers the growth of CRRT. Moreover, ongoing innovation and research activities, including developing novel membrane materials and advanced therapy options with improved biocompatibility and widening uses of CCRT systems for pediatric patients, contribute to the future CRRT.
Regional Insights
In the Americas, countries such as the United States and Canada hold a significant share of the CRRT market, with the major factors driving the growth, including the increasing prevalence of renal diseases and technological advancements and research & development activities by major companies. Additionally, in Europe, the presence of leading manufacturers, increased need for advanced therapies, and supportive government policies, such as European CE marking for renal therapy products, contribute to the expansion of the CRRT market. On the other hand, the Middle East and Africa region has witnessed a growth in need for CRRT solutions due to rising awareness about renal diseases and continuously developing healthcare infrastructure adopting new treatment options supported by clinical studies. In Asia-Pacific, China, Japan, and India are major contributors to the CRRT market growth due to factors including a large patient pool with kidney disorders, a growing medical tourism industry, and expanding healthcare infrastructure, coupled with an increasing focus on research initiatives enabling rapid adoption of advanced technologies in this region. As a result, manufacturers remain agile by adapting regulatory compliance measures and participating in strategic collaborations with governments and entities to form footprints in the CRRT market.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Continuous Renal Replacement Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Renal Replacement Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment Co., Ltd., Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Biomedica Medizinprodukte GmbH, Braun & Co. Limited, CytoSorbents Corporation, DIAMED Medizintechnik GmbH, Fresenius Medical Care AG & Co. KGaA, Infomed SA, Joline GmbH & Co. KG, Medites Pharma spol. s.r.o, Medtronic PLC, Miromatrix Medical Inc., Nextkidney B.V., Nikkiso Co., Ltd., Ningbo Tianyi Medical Devices Co., Ltd., Nipro Corporation, Nuwellis, Inc., Quanta Dialysis Technologies Limited, SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, Sphingotec GmbH, SWS Hemodialysis Care Co. Ltd., Thermo Fisher Scientific Inc., and Toray Medical Co., Ltd. by Toray Industries, Inc.Market Segmentation & Coverage
This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- CRRT Systems
- Dialysates & Replacement Fluids
- Disposables
- Bodyline sets & tubes
- Hemofilters
- Modality
- Continuous Venovenous Hemodiafiltration
- Continuous Venovenous Hemodialysis
- Continuous Venovenous Hemofiltration
- Slow Continuous Ultrafiltration
- Age Group
- Adults
- Pediatrics
- Indication
- Non-renal
- Renal
- End User
- Dialysis Clinics
- Homecare
- Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as
- What is the market size and forecast of the Continuous Renal Replacement Therapy Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Renal Replacement Therapy Market?
- What are the technology trends and regulatory frameworks in the Continuous Renal Replacement Therapy Market?
- What is the market share of the leading vendors in the Continuous Renal Replacement Therapy Market?
- Which modes and strategic moves are suitable for entering the Continuous Renal Replacement Therapy Market?
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Continuous Renal Replacement Therapy Market, by Product
7. Continuous Renal Replacement Therapy Market, by Modality
8. Continuous Renal Replacement Therapy Market, by Age Group
9. Continuous Renal Replacement Therapy Market, by Indication
10. Continuous Renal Replacement Therapy Market, by End User
11. Americas Continuous Renal Replacement Therapy Market
12. Asia-Pacific Continuous Renal Replacement Therapy Market
13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market
14. Competitive Landscape
15. Competitive Portfolio
16. Appendix
List of Figures
Companies Mentioned
- Anjue Medical Equipment Co., Ltd.
- Asahi Kasei Medical Co., Ltd.
- B. Braun SE
- Baxter International Inc.
- Biomedica Medizinprodukte GmbH
- Braun & Co. Limited
- CytoSorbents Corporation
- DIAMED Medizintechnik GmbH
- Fresenius Medical Care AG & Co. KGaA
- Infomed SA
- Joline GmbH & Co. KG
- Medites Pharma spol. s.r.o
- Medtronic PLC
- Miromatrix Medical Inc.
- Nextkidney B.V.
- Nikkiso Co., Ltd.
- Ningbo Tianyi Medical Devices Co., Ltd.
- Nipro Corporation
- Nuwellis, Inc.
- Quanta Dialysis Technologies Limited
- SB-KAWASUMI LABORATORIES, INC.
- Shionogi & Company, Limited
- Sphingotec GmbH
- SWS Hemodialysis Care Co. Ltd.
- Thermo Fisher Scientific Inc.
- Toray Medical Co., Ltd. by Toray Industries, Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 187 |
Published | March 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 14.28 Billion |
Forecasted Market Value ( USD | $ 25.37 Billion |
Compound Annual Growth Rate | 8.5% |
Regions Covered | Global |
No. of Companies Mentioned | 26 |